Aug 2023 $200 M No. 7 $50 to $250 million 28
ADARx Pharmaceuticals, Inc.: Raise no. 7, Aug 2023 × Investors in this round 28 investors had bought by the notice of Aug 10, 2023: 28 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for ADARx Pharmaceuticals, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $200 M of $200 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Rui Zhu · Executive Officer Zhen Li · Executive Officer, Director, Promoter Carl Gordon · Director Chen Yu · Director Erez Chimovits · Director Judith Li · Director Lorence Kim · Director Ricky Sun · Director Sheila Gujrathi · Director Simeon George · Director Yuan (Eliza) Sun · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Zhen Li, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 10, 2023. Read the notice at the SEC .
equity SEC Jan 2023 $46 M No. 6 $10 to $50 million 10
ADARx Pharmaceuticals, Inc.: Raise no. 6, Jan 2023 × Investors in this round 10 investors had bought by the notice of Jan 26, 2023: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for ADARx Pharmaceuticals, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $46 M of $46 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Rui Zhu · Executive Officer Zhen Li · Executive Officer, Director Carl Gordon · Director Erez Chimovits · Director Judith Li · Director Lorence Kim · Director Sheila Gujrathi · Director Simeon George · Director Yuan (Eliza) Sun · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Zhen Li, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 26, 2023. Read the notice at the SEC .
equity SEC Jul 2021 $75 M No. 5 $50 to $250 million 6
ADARx Pharmaceuticals, Inc.: Raise no. 5, Jul 2021 × Investors in this round 6 investors had bought by the notice of Aug 17, 2021: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for ADARx Pharmaceuticals, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $75 M of $75 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Rui Zhu · Executive Officer Zhen Li · Executive Officer, Director Carl Gordon · Director Erez Chimovits · Director Sheila Gujrathi · Director Simeon George · Director Xiong Zhang · Director Yuan Sun · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Zhen Li, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 17, 2021. Read the notice at the SEC .
equity SEC May 2021 $16 M No. 4 $10 to $50 million 3
ADARx Pharmaceuticals, Inc.: Raise no. 4, May 2021 × Investors in this round 3 investors had bought by the notice of May 24, 2021: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for ADARx Pharmaceuticals, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $16 M of $16 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Rui Zhu · Executive Officer Zhen Li · Executive Officer, Director Carl Gordon · Director Erez Chimovits · Director Sheila Gujrathi · Director Xiong Zhang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Zhen Li, President & CEO. Source: SEC Form D, newest notice filed May 24, 2021. Read the notice at the SEC .
equity SEC Nov 2020 $6 M No. 3 $2 to $10 million 3
ADARx Pharmaceuticals, Inc.: Raise no. 3, Nov 2020 × Investors in this round 3 investors had bought by the notice of Nov 17, 2020: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for ADARx Pharmaceuticals, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Rui Zhu · Executive Officer Zhen Li · Executive Officer, Director Carl Gordon · Director Erez Chimovits · Director Hongbo Lu · Director Sheila Gujrathi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Zhen Li, President & CEO. Source: SEC Form D, newest notice filed Nov 17, 2020. Read the notice at the SEC .
equity SEC Jul 2020 $5 M No. 2 $2 to $10 million 3
ADARx Pharmaceuticals, Inc.: Raise no. 2, Jul 2020 × Investors in this round 3 investors had bought by the notice of Aug 7, 2020: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for ADARx Pharmaceuticals, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Rui Zhu · Executive Officer Zhen Li · Executive Officer, Director Carl Gordon · Director Erez Chimovits · Director Hongbo Lu · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes amounts paid both in cash and pursuant to automatic conversion of indebtedness.”Signed by Zhen Li, President & CEO. Source: SEC Form D, newest notice filed Aug 7, 2020. Read the notice at the SEC .
equity SEC Jan 2020 $5 M No. 1 $2 to $10 million 3
ADARx Pharmaceuticals, Inc.: Raise no. 1, Jan 2020 × Investors in this round 3 investors had bought by the notice of Feb 6, 2020: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for ADARx Pharmaceuticals, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Rui Zhu · Executive Officer Zhen Li · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Zhen Li, President & CEO. Source: SEC Form D, newest notice filed Feb 6, 2020. Read the notice at the SEC .
debt, options SEC